Akero Therapeutics, Inc. Common Stock, Value, Issued
Akero Therapeutics, Inc. had Common Stock, Value, Issued of $8.00 thousand as of 2025-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2025-11-07
- 2025-09-30: Common Stock, Value, Issued $8.00K.
- 2025-06-30: Common Stock, Value, Issued $8.00K.
- 2025-03-31: Common Stock, Value, Issued $8.00K.
- 2024-12-31: Common Stock, Value, Issued $7.00K.
| Period end | Common Stock, Value, Issued |
|---|---|
| 2025-09-30 | $8.00K 10-Q · filed 2025-11-07 |
| 2025-06-30 | $8.00K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $8.00K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $7.00K 10-Q · filed 2025-11-07 |
| 2024-09-30 | $7.00K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $7.00K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $7.00K 10-Q · filed 2024-05-10 |
| 2023-12-31 | $6.00K 10-K · filed 2025-02-28 |
| 2023-09-30 | $6.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $6.00K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $5.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $5.00K 10-K · filed 2024-02-29 |
| 2022-09-30 | $5.00K 10-Q · filed 2022-11-04 |
| 2022-06-30 | $4.00K 10-Q · filed 2022-08-05 |
| 2022-03-31 | $4.00K 10-Q · filed 2022-05-06 |
| 2021-12-31 | $4.00K 10-K · filed 2023-03-17 |
| 2021-09-30 | $4.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $4.00K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $4.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $4.00K 10-K · filed 2022-02-25 |
| 2020-09-30 | $4.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $3.00K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $3.00K 10-Q · filed 2020-05-13 |
| 2019-12-31 | $3.00K 10-K · filed 2021-03-16 |
| 2019-09-30 | $3.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $3.00K 10-Q · filed 2019-08-12 |